JScopeJapan Capex

Riken Vitamin Co., Ltd.

TSE 45263 tracked projects¥6.7B disclosed

Sectors

R&D Facilities, Food & Beverage

Where it builds

Tokyo, Oklahoma, Gifu

Stage

2 planned · 1 building

Every tracked project

3
PostedProjectSectorLocationInvestmentPhase
2026.08.14Riken Vitamin to build Material Nexus Lab R&D center at Tokyo PlantRiken Vitamin will build the Material Nexus Lab, a new R&D facility for chemical-product additives at its Tokyo Plant in Itabashi, Tokyo. The facility will consolidate R&D functions from the Osaka Plant and subsidiary Kenseido, with completion planned for March 2028 and operations beginning in April 2028.R&D FacilitiesItabashi, Tokyo¥1.6BPlanned
2026.08.12Riken Vitamin to expand production capacity at Oklahoma facilityRiken Vitamin plans production-capacity expansion work at its Guymon Extracts facility in Oklahoma, United States. The project is scheduled to start in December 2023 and be completed in August 2027, adding 500 tonnes of capacity; the total planned investment is JPY 1.54 billion funded internally.Food & BeverageOklahoma¥1.5BBuilding
2026.07.21Riken Vitamin acquires 48,000 sqm plant site in Anpachi, Gifu to relocate Kyoto plantRiken Vitamin has acquired about 48,000 square metres in Anpachi, Gifu for approximately ¥3.6 billion, to build a plant that will take over from its Kyoto plant. The site will make colour products including crocetin and gardenia blue pigment, expanding production capacity. The sale contract was signed in June 2026, ownership transfers in autumn 2027, and the company is targeting operation in fiscal 2030.Food & BeverageAnpachi, Gifu¥3.6BPlanned

Also building in R&D Facilities

Browse the sector: R&D Facilities, Food & Beverage.